Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections

Clinical trial NCT03840616 · COMPLETED

Trial details

NCT number: NCT03840616
Sponsor: Mycovia Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Vulvovaginal Candidiasis

Start date: 2019-03-13
Primary completion: 2020-12-02
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.